MANZO PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | -.--% |
| May. 21 | Manzo Pharmaceuticals, Inc. announced that it expects to receive $0.0005 million in funding | CI |
| 2015 | Manzo Pharmaceuticals Inc. Announces New Product Somnaid Release | CI |
Volumes
marketsDaily volume
200
Estimated daily volume
200
Record volume 1
138 320 100
Record volume 2
136 135 300
Record volume 3
135 640 800
Capital turnover ratio
0.00
Basic data
Capitalization (USD)
1 099
Net sales (USD)
3 069 747
Number of employees
12
Sales / Employee (USD)
255 812
Free-Float
0 %
Free-Float capitalization (USD)
0
Highs and lows
3 years
0.00
0.00
5 years
0.000.00
10 years
0.000.02
Indicators
RSI 9 days
0.00
RSI 14 days
0.00
Sector Comparison - Specialty & Advanced Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 1.1K | ||
| -0.16% | +3.06% | +19.08% | +1.51% | 81.33B | ||
| +0.43% | +1.85% | +14.11% | -0.39% | 9.14B | ||
| -1.39% | +1.31% | -15.14% | +14.67% | 4.89B | ||
| +1.18% | -6.60% | +46.88% | +106.15% | 4.61B | ||
| +1.40% | +14.04% | +15.70% | +37.24% | 4.36B | ||
| -1.03% | -10.76% | +8.82% | -24.85% | 2.26B | ||
| -2.36% | -2.29% | -27.88% | -30.14% | 2.15B | ||
| 0.00% | -0.26% | +15.73% | -1.05% | 2.1B | ||
| -4.20% | -9.19% | -43.02% | -51.89% | 1.78B | ||
| -.--% | -.--% | - | - | 1.64B | ||
| -1.42% | +2.18% | -6.19% | -21.51% | 1.49B | ||
| -4.21% | -6.27% | -8.70% | -7.22% | 1.12B | ||
| -1.67% | +3.99% | -15.10% | -30.55% | 1.09B | ||
| -0.14% | -0.38% | +63.18% | +130.57% | 1.07B | ||
| +2.19% | +19.49% | +62.26% | +54.55% | 1.05B | ||
| Average | -0.71% | +0.90% | +9.27% | +12.65% | ||
| Weighted average by Cap. | -0.21% | +3.42% | +16.09% | +6.33% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -.--% | ||
| 2023 | -99.00% | ||
| 2022 | -88.89% | ||
| 2021 | +89,900.00% | ||
| 2020 | -99.00% | ||
| 2019 | +9,900.00% | ||
| 2018 | -99.67% | ||
| 2017 | +200.00% | ||
| 2016 | -83.33% | ||
| 2015 | -50.00% | ||
| 2014 | +20.00% | ||
| 2013 | -.--% | ||
| 2012 | -75.00% | ||
| 2011 | -95.29% | ||
| 2010 | +750.00% | ||
| 2009 | +233.33% | ||
| 2008 | -92.68% | ||
| 2007 | -79.50% | ||
| 2006 | -33.33% | ||
| 2005 | -40.00% | ||
| 2004 | -44.44% | ||
| 2003 | -76.32% | ||
| 1999 | +46.15% | ||
| 1998 | -99.42% | ||
| 1997 | -96.00% | ||
| 1996 | -64.00% | ||
| 1995 | +38.89% | ||
| 1994 | -51.35% | ||
| 1993 | +48.00% | ||
| 1992 | -32.43% |
- Stock Market
- Equities
- MNZO Stock
- Quotes Manzo Pharmaceuticals, Inc.
